Literature DB >> 23126521

Prenatal antidepressant exposure and behavioral problems in early childhood--a cohort study.

L H Pedersen1, T B Henriksen, B H Bech, R W Licht, D Kjaer, J Olsen.   

Abstract

OBJECTIVE: To estimate a potential association between in utero exposure to antidepressants and behavioral problems in childhood.
METHOD: Information on exposures was obtained from the Danish National Birth Cohort. We studied the children of 127 mothers who had used antidepressants during pregnancy and compared these to 98 children of mothers with a prenatal depression with no use of antidepressants during pregnancy and 723 children of mothers with no prenatal depression and no use of antidepressant during pregnancy (unexposed). Behavioral problems were assessed at 4 or 5 years of age by the parent-reported Strengths and Difficulties Questionnaire (SDQ).
RESULTS: Prenatal antidepressant exposure was not associated with abnormal SDQ scores compared with prenatal exposure to untreated prenatal depression or to no exposure. Untreated prenatal depression was associated with abnormal SDQ scores in the subscales of conduct [adjusted odds ratio (aOR) 2.3 (95% CI, 1.2-4.5)] and prosocial problems [aOR 3.0 (95% CI, 1.2-7.8)] compared with unexposed children. Total SDQ score was higher in children of mothers with untreated prenatal depression. These associations attenuated after adjusting for postnatal maternal psychiatric disease.
CONCLUSION: Prenatal antidepressant exposure was not associated with behavioral or emotional problems in early childhood.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23126521     DOI: 10.1111/acps.12032

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

1.  Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring.

Authors:  Alexander Viktorin; Rudolf Uher; Alexander Kolevzon; Abraham Reichenberg; Stephen Z Levine; Sven Sandin
Journal:  JAMA Psychiatry       Date:  2017-10-01       Impact factor: 21.596

Review 2.  Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.

Authors:  Tamar L Gur; Deborah R Kim; C Neill Epperson
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

3.  Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated depression.

Authors:  Tone Kristine Hermansen; Espen Røysamb; Else-Marie Augusti; Annika Melinder
Journal:  Psychopharmacology (Berl)       Date:  2016-02-29       Impact factor: 4.530

Review 4.  Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.

Authors:  Hanan El Marroun; Tonya White; Frank C Verhulst; Henning Tiemeier
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-05-27       Impact factor: 4.785

5.  Prenatal Depression Risk Factors, Developmental Effects and Interventions: A Review.

Authors:  Tiffany Field
Journal:  J Pregnancy Child Health       Date:  2017-02-27

6.  Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes.

Authors:  Aimee K Santucci; Lynn T Singer; Stephen R Wisniewski; James F Luther; Heather F Eng; John L Dills; Dorothy K Y Sit; Barbara H Hanusa; Katherine L Wisner
Journal:  J Clin Psychiatry       Date:  2014-10       Impact factor: 4.384

Review 7.  Prenatal Antidepressant Exposure and Childhood Autism Spectrum Disorders: Cause for Concern?

Authors:  Lars Henning Pedersen
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

Review 8.  [Affective disorders during pregnancy : Therapy with antidepressants and mood stabilizers].

Authors:  N Bergemann; W E Paulus
Journal:  Nervenarzt       Date:  2016-09       Impact factor: 1.214

9.  Maternal psychological distress in primary care and association with child behavioural outcomes at age three.

Authors:  Stephanie L Prady; Kate E Pickett; Tim Croudace; Dan Mason; Emily S Petherick; Rosie R C McEachan; Simon Gilbody; John Wright
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-09-28       Impact factor: 4.785

10.  Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study.

Authors:  Mollie E Wood; Jean A Frazier; Hedvig M E Nordeng; Kate L Lapane
Journal:  BMJ Open       Date:  2016-09-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.